A combination of Cotellic and Tecentriq failed to beat Keytruda monotherapy in newly diagnosed patients with non-mutated melanoma in a Phase 3 trial, according to an...

Regeneron and Sanofi said Friday their experimental IL-33 antibody improved asthma control better than placebo in a Phase 2 study.But REGN3500 didn't beat the two dr...

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in t...

The Food and Drug Administration has lifted a clinical hold on one multiple myeloma trial for AbbVie's Venclexta after making several changes to the study protocols,...